Activation of GPR120 with its agonists such as docosahexaenoic acid (DHA) has an insulinotropic effect on pancreatic beta-cell secretion and survival, with therapeutic potential for obesity-associated type 2 diabetes [14]. The gene discussed is FFAR4; the disease is obesity due to melanocortin 4 receptor deficiency.